Neuronal DJ-1 regulates microglial activation in Parkinson's disease

Aonan Zhao1, Yanfei Ding1, Min Zhong1

  • 1Department of Neurology and Institute of Neurology, Ruijin Hospital Affiliated to the Shanghai Jiao Tong University School of Medicine, Shanghai, China.

PubMed
Abstract

No abstract available in PubMed .

Insights

DJ-1 (Parkinson's disease protein 7) protects neurons by regulating microglia communication via CX3CL1. Restoring this pathway may offer new Parkinson's disease therapies.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • DJ-1 (Parkinson's disease protein 7) is crucial for neuroprotection and oxidative stress regulation.
  • Its role in Parkinson's disease neuroinflammation and microglia-neuron communication is not fully understood.

Purpose of the Study:

  • To investigate DJ-1's role in microglia-neuron communication.
  • To identify therapeutic targets for Parkinson's disease neuroinflammation.

Main Methods:

  • Utilized Park7 knockout mice and Park7 knockdown SH-SY5Y cells.
  • Performed protein microarray analysis and validated with GEO datasets.
  • Assessed the impact of DJ-1 deficiency on CX3CL1 processing and microglial activation.

Main Results:

  • Park7 deficiency decreased CX3CL1, monocyte chemoattractant protein-1, and interleukin-8 levels.
  • Reduced ADAM10 processing in Park7-deficient models led to lower CX3CL1 secretion.
  • This resulted in pro-inflammatory M1 microglial activation, which was reversed by exogenous CX3CL1.

Conclusions:

  • DJ-1 protects dopaminergic neurons by suppressing microglial activation via CX3CL1 regulation.
  • The DJ-1/CX3CL1 axis is a potential therapeutic target for Parkinson's disease neuroinflammation.